Stocks and Investing Stocks and Investing
Mon, December 14, 2020
Fri, December 11, 2020
Thu, December 10, 2020
Wed, December 9, 2020
Tue, December 8, 2020
Mon, December 7, 2020

David Lebowitz Maintained (SNDX) at Hold with Increased Target to $25 on, Dec 7th, 2020


Published on 2024-10-27 14:56:43 - WOPRAI
  Print publication without navigation


David Lebowitz of Morgan Stanley, Maintained "Syndax Pharmaceuticals, Inc." (SNDX) at Hold with Increased Target from $17 to $25 on, Dec 7th, 2020.

David has made no other calls on SNDX in the last 4 months.



There is 1 other peer that has a rating on SNDX. Out of the 1 peers that are also analyzing SNDX, 0 agree with David's Rating of Hold.



This is the rating of the analyst that currently disagrees with David


  • Konstantinos Aprilakis of "Stifel" Initiated at Strong Buy and Held Target at $32 on, Thursday, December 3rd, 2020